224 related articles for article (PubMed ID: 23306053)
21. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.
Pickl M; Ries CH
Oncogene; 2009 Jan; 28(3):461-8. PubMed ID: 18978815
[TBL] [Abstract][Full Text] [Related]
22. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Yoshii Y; Waki A; Yoshida K; Kakezuka A; Kobayashi M; Namiki H; Kuroda Y; Kiyono Y; Yoshii H; Furukawa T; Asai T; Okazawa H; Gelovani JG; Fujibayashi Y
Biomaterials; 2011 Sep; 32(26):6052-8. PubMed ID: 21640378
[TBL] [Abstract][Full Text] [Related]
23. Multicellular tumor spheroids: an underestimated tool is catching up again.
Hirschhaeuser F; Menne H; Dittfeld C; West J; Mueller-Klieser W; Kunz-Schughart LA
J Biotechnol; 2010 Jul; 148(1):3-15. PubMed ID: 20097238
[TBL] [Abstract][Full Text] [Related]
24. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
25. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
26. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
27. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
28. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
29. Applicability of tumor spheroids for
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
[No Abstract] [Full Text] [Related]
30. Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.
Fayad W; Rickardson L; Haglund C; Olofsson MH; D'Arcy P; Larsson R; Linder S; Fryknäs M
Chem Biol Drug Des; 2011 Oct; 78(4):547-57. PubMed ID: 21726416
[TBL] [Abstract][Full Text] [Related]
31. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
32. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
Chen MC; Gupta M; Cheung KC
Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
[TBL] [Abstract][Full Text] [Related]
33. Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration.
Ma HL; Jiang Q; Han S; Wu Y; Cui Tomshine J; Wang D; Gan Y; Zou G; Liang XJ
Mol Imaging; 2012; 11(6):487-98. PubMed ID: 23084249
[TBL] [Abstract][Full Text] [Related]
34. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
35. A multicellular spheroid-based drug sensitivity test by scanning electrochemical microscopy.
Torisawa YS; Takagi A; Shiku H; Yasukawa T; Matsue T
Oncol Rep; 2005 Jun; 13(6):1107-12. PubMed ID: 15870929
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells.
Oshikata A; Matsushita T; Ueoka R
J Biosci Bioeng; 2011 May; 111(5):590-3. PubMed ID: 21354366
[TBL] [Abstract][Full Text] [Related]
37. Large-scale pharmacological profiling of 3D tumor models of cancer cells.
Mathews Griner LA; Zhang X; Guha R; McKnight C; Goldlust IS; Lal-Nag M; Wilson K; Michael S; Titus S; Shinn P; Thomas CJ; Ferrer M
Cell Death Dis; 2016 Dec; 7(12):e2492. PubMed ID: 27906188
[TBL] [Abstract][Full Text] [Related]
38. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional perfused tumour spheroid model for anti-cancer drug screening.
Wan X; Li Z; Ye H; Cui Z
Biotechnol Lett; 2016 Aug; 38(8):1389-95. PubMed ID: 27167883
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
